All In MedTech

FDA Clearance Tracker · P960053

BRAUN-CUTTER TRAPEZO-METACARPAL PROSTHESIS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jun 19, 1997 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Jun 19, 1997

Approved

Time to decision

177 days

Received Dec 24, 1996. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P960053
Device name
BRAUN-CUTTER TRAPEZO-METACARPAL PROSTHESIS
Applicant location
Selzach
Received
Dec 24, 1996
Decided
Jun 19, 1997
Decision
Approved
Supplements
5 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 888.3220

Every decision under product code KWG

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE AVANTA BRAUN-CUTTER TRAPEZO-METACARPAL PROSTHESIS. THIS DEVICE IS INDICATED FOR TOTAL JOINT REPLACEMENT IN SKELETALLY MATURE PATIENTS WITH PAIN OR INSTABILITY OF THE TRAPEZO-METACARPAL JOINT DUE TO TRAUMA, INFLAMMATORY OR DEGENERATIVE DISEASE OR REVISION OF PREVIOUS PROCEDURES, AS AN ALTERNATIVE TO ARTHRODESIS OR RECONSTRUCTIVE SURGERY.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code KWG (Prosthesis, finger, constrained, metal/polymer).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Stryker Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.